Animal models of Parkinson's disease. (Q34596189)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

review article

1 reference

title

Animal models of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

J. Timothy Greenamyre

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Ranjita Betarbet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Todd B Sherer

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

308-318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

Anatomical and chemical studies of a nigro-neostriatal projection in the cat.

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

The functional anatomy of basal ganglia disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Neural mechanisms in disorders of movement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Primate models of movement disorders of basal ganglia origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

NMDA-dependent superoxide production and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Mechanisms of action of 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

6-hydroxy-dopamine induced degeneration of central monoamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

A 6-hydroxydopamine-induced selective parkinsonian rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Pesticides and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Creatine and cyclocreatine attenuate MPTP neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Bioenergetics and glutamate excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Novel free radical spin traps protect against malonate and MPTP neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Protein nitration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Gro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Transgenic models of tauopathies and synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

The ubiquitin pathway in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Interaction of alpha-phenyl-N-tert-butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Mitochondrial oxidative phosphorylation defects in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Effect of coadministration of glutamate receptor antagonists and dopaminergic agonists on locomotion in monoamine-depleted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Free radical-generated neurotoxicity of 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Inhibitors of NADH-ubiquinone reductase: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067